A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Safety, Tolerability, and Pharmacokinetic Study of EDP-788 in Healthy Adult Volunteers

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Safety, Tolerability, and Pharmacokinetic Study of EDP-788 in Healthy Adult Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 15 May 2015

At a glance

  • Drugs EDP 788 (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections
  • Focus Adverse reactions
  • Sponsors Enanta Pharmaceuticals
  • Most Recent Events

    • 11 May 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
    • 09 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top